[1]
Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleveland Clinic journal of medicine. 2016 Jan:83(1):37-42. doi: 10.3949/ccjm.83a.14120. Epub
[PubMed PMID: 26760521]
[2]
van der Veen KJ, Willebrands AF. Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera. Clinica chimica acta; international journal of clinical chemistry. 1966 Mar:13(3):312-6
[PubMed PMID: 5943823]
[3]
Dawson DM, Eppenberger HM, Kaplan NO. Creatine kinase: evidence for a dimeric structure. Biochemical and biophysical research communications. 1965 Nov 22:21(4):346-53
[PubMed PMID: 5865501]
[4]
Lee TH,Goldman L, Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Annals of internal medicine. 1986 Aug;
[PubMed PMID: 3524337]
[5]
Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clinical chemistry. 1986 Aug:32(8):1568-70
[PubMed PMID: 3731455]
[6]
Clark GL, Robison AK, Gnepp DR, Roberts R, Sobel BE. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circulation research. 1978 Aug:43(2):162-9
[PubMed PMID: 27320]
[7]
Sobel BE, Markham J, Karlsberg RP, Roberts R. The nature of disappearance of creatine kinase from the circulation and its influence on enzymatic estimation of infarct size. Circulation research. 1977 Dec:41(6):836-44
[PubMed PMID: 923034]
[8]
Karlsberg RP, Roberts R. Effect of altered thyroid function on plasma creatine kinase clearance in the dog. The American journal of physiology. 1978 Dec:235(6):E614-8
[PubMed PMID: 736119]
[9]
Trask RV, Billadello JJ. Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochimica et biophysica acta. 1990 Jun 21:1049(2):182-8
[PubMed PMID: 2364108]
[10]
Fontanet HL, Trask RV, Haas RC, Strauss AW, Abendschein DR, Billadello JJ. Regulation of expression of M, B, and mitochondrial creatine kinase mRNAs in the left ventricle after pressure overload in rats. Circulation research. 1991 Apr:68(4):1007-12
[PubMed PMID: 2009604]
[11]
Keshgegian AA, Feinberg NV. Serum creatine kinase MB isoenzyme in chronic muscle disease. Clinical chemistry. 1984 Apr:30(4):575-8
[PubMed PMID: 6705202]
[12]
Jockers-Wretou E, Grabert K, Müller E, Pfleiderer G. Serum creatine kinase isoenzyme pattern in nervous system atrophies and neuromuscular disorders. Clinica chimica acta; international journal of clinical chemistry. 1976 Nov 15:73(1):183-6
[PubMed PMID: 1000828]
[13]
Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. The Journal of laboratory and clinical medicine. 1984 Aug:104(2):193-202
[PubMed PMID: 6747438]
[14]
Schuyler GT, Yarbrough LR. Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism. Basic research in cardiology. 1990 Sep-Oct:85(5):481-94
[PubMed PMID: 1703406]
[15]
Abbott LB, Lott JA. Reactivation of serum creatine kinase isoenzyme BB in patients with malignancies. Clinical chemistry. 1984 Nov:30(11):1861-3
[PubMed PMID: 6435914]
[16]
Lippi G, von Meyer A, Cadamuro J, Simundic AM. Blood sample quality. Diagnosis (Berlin, Germany). 2019 Mar 26:6(1):25-31. doi: 10.1515/dx-2018-0018. Epub
[PubMed PMID: 29794250]
Level 2 (mid-level) evidence
[17]
Kanemitsu F, Okigaki T. Creatine kinase isoenzymes. Journal of chromatography. 1988 Jul 29:429():399-417
[PubMed PMID: 3062028]
[18]
Chen A, Wong SS. Differentiation of creatine kinase MB and IgA-linked BB isoenzymes on electrophoresis. FEBS letters. 1987 Apr 6:214(1):192-4
[PubMed PMID: 3494633]
Level 3 (low-level) evidence
[19]
Ogunro EA, Hearse DJ, Shillingford JP. Creatine kinase isoenzymes: their separation and quantitation. Cardiovascular research. 1977 Mar:11(2):94-102
[PubMed PMID: 870200]
[20]
Laurino JP, Fischberg-Bender E, Galligan S, Chang J. An immunochemical mass assay for the direct measurement of creatine kinase MB2. Annals of clinical and laboratory science. 1995 May-Jun:25(3):252-63
[PubMed PMID: 7605108]
[21]
Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clinica chimica acta; international journal of clinical chemistry. 2004 Aug 16:346(2):211-9
[PubMed PMID: 15256323]
[22]
Marwah SA, Shah H, Chauhan K, Trivedi A, Haridas N. Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction. Indian journal of clinical biochemistry : IJCB. 2014 Apr:29(2):161-6. doi: 10.1007/s12291-013-0329-9. Epub 2013 May 15
[PubMed PMID: 24757297]
[23]
Seo H, Miyazaki S, Furuno T, Nonogi H, Haze K, Hiramori K. Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level. Japanese heart journal. 1993 Nov:34(6):717-27
[PubMed PMID: 8164339]
[24]
Obzansky D, Lott JA. Clinical evaluation of an immunoinhibition procedure for creatine kinase-MB. Clinical chemistry. 1980 Jan:26(1):150-2
[PubMed PMID: 7356551]
[25]
Smith AF, Radford D, Wong CP, Oliver MF. Creatine kinase MB isoenzyme studies in diagnosis of myocardial infarction. British heart journal. 1976 Mar:38(3):225-32
[PubMed PMID: 1259837]
[26]
Mair J, Artner-Dworzak E, Dienstl A, Lechleitner P, Morass B, Smidt J, Wagner I, Wettach C, Puschendorf B. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. The American journal of cardiology. 1991 Dec 15:68(17):1545-50
[PubMed PMID: 1746453]
[27]
Eisenberg PR, Shaw D, Schaab C, Jaffe AS. Concordance of creatine kinase-MB activity and mass. Clinical chemistry. 1989 Mar:35(3):440-3
[PubMed PMID: 2646033]
[28]
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 2000 Sep:36(3):959-69
[PubMed PMID: 10987628]
Level 3 (low-level) evidence
[29]
el Allaf M, Chapelle JP, el Allaf D, Adam A, Faymonville ME, Laurent P, Heusghem C. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clinical chemistry. 1986 Feb:32(2):291-5
[PubMed PMID: 3510780]
[30]
Wolfson D, Lindberg E, Su L, Farber SJ, Dubin SB. Three rapid immunoassays for the determination of creatine kinase MB: an analytical, clinical, and interpretive evaluation. American heart journal. 1991 Oct:122(4 Pt 1):958-64
[PubMed PMID: 1927882]
[31]
Adams JE 3rd, Bodor GS, Dávila-Román VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993 Jul:88(1):101-6
[PubMed PMID: 8319322]
[32]
Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2005 Nov 8:173(10):1191-202
[PubMed PMID: 16275971]
[33]
Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. The American journal of cardiology. 1991 Jun 15:67(16):1360-7
[PubMed PMID: 1904190]
[34]
Adams JE 3rd, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clinical chemistry. 1994 Jul:40(7 Pt 1):1291-5
[PubMed PMID: 8013101]
[35]
Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991 Mar:83(3):902-12
[PubMed PMID: 1999039]
[36]
Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kübler W, Katus HA. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. Journal of molecular and cellular cardiology. 1995 Feb:27(2):793-803
[PubMed PMID: 7776386]
[37]
Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clinical chemistry. 1998 Sep:44(9):1919-24
[PubMed PMID: 9732977]
[38]
Anderson PA, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circulation research. 1991 Nov:69(5):1226-33
[PubMed PMID: 1934353]
[39]
Müller-Bardorff M, Hallermayer K, Schröder A, Ebert C, Borgya A, Gerhardt W, Remppis A, Zehelein J, Katus HA. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clinical chemistry. 1997 Mar:43(3):458-66
[PubMed PMID: 9068589]
Level 1 (high-level) evidence
[40]
Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. Journal of clinical pathology. 2013 Dec:66(12):1027-32. doi: 10.1136/jclinpath-2013-201661. Epub 2013 Sep 26
[PubMed PMID: 24072731]
Level 2 (mid-level) evidence
[41]
Badrick T. Integrating quality control and external quality assurance. Clinical biochemistry. 2021 Sep:95():15-27. doi: 10.1016/j.clinbiochem.2021.05.003. Epub 2021 May 7
[PubMed PMID: 33965412]
Level 2 (mid-level) evidence
[42]
Peng S, Zhang J, Zhou W, Mao W, Han Z. Practical application of Westgard Sigma rules with run size in analytical biochemistry processes in clinical settings. Journal of clinical laboratory analysis. 2021 Mar:35(3):e23665. doi: 10.1002/jcla.23665. Epub 2020 Dec 3
[PubMed PMID: 33270940]
[43]
James D, Ames D, Lopez B, Still R, Simpson W, Twomey P. External quality assessment: best practice. Journal of clinical pathology. 2014 Aug:67(8):651-5. doi: 10.1136/jclinpath-2013-201621. Epub 2014 Mar 12
[PubMed PMID: 24621574]
Level 2 (mid-level) evidence
[44]
Carter JY. External quality assessment in resource-limited countries. Biochemia medica. 2017 Feb 15:27(1):97-109. doi: 10.11613/BM.2017.013. Epub
[PubMed PMID: 28392732]
Level 2 (mid-level) evidence
[45]
Ménard AD, Trant JF. A review and critique of academic lab safety research. Nature chemistry. 2020 Jan:12(1):17-25. doi: 10.1038/s41557-019-0375-x. Epub 2019 Nov 18
[PubMed PMID: 31740762]
[46]
Kennedy BW. Safety training. Lab animal. 2015 Apr:44(4):151. doi: 10.1038/laban.725. Epub
[PubMed PMID: 25793682]
Level 3 (low-level) evidence